Pneumonia. Community acquired: o Person to person Bacterial: Classical bacterial pneumonia Atypical bacterial pneumonia Viral pneumonia.

Pneumonia

Barriers to infection:• Epiglottis: protects airway from aspiration.• Cough reflex*.• Mucociliary escalator.• Alveolar macrophage & antimicrobial.

compounds: lysozyme, lactoferrin, complement and IgA.

Pneumonia:Inflammation of the lung parenchyma: Inflammation of alveoli, alveolar ducts, bronchioles, and interstitial tissue of lung, induced by microbial invasion of natural barriers.

Classification of pneumonia: Clinical Classification: • Acute: less than three weeks duration • Chronic pneumonias. Acute pneumonia is further classified

according to place where it was acquired, source of transmission, and etiology.

Classification of Acute Pneumonia: Community acquired:o Person to person Bacterial:Classical bacterial pneumoniaAtypical bacterial pneumonia

Viral pneumoniao Animal, or Environmental Exposure.

Nosocomial acquired.

Community-acquired acute pneumonia: Person-to-Person: A- Classic bacterial pneumonia: • Streptococcus pneumoniae.• Haemophilus influenzae.• Klebsiella pneumoniae.• Moraxella catarrhalis.• Aspiration pneumonia* (mixture of bacteria

including gram negatives, anaerobes and Staphylococcus aureus).

N

Person to Person: B- Atypical bacterial pneumonia:• Chlamydophila pneumoniae• Mycoplasma pneumoniae.

C- Viral pneumonia:• Influenza virus type A, B, and C• Coronaviruses.• Others: RSV, measles, adenoviruses,

CMV…..

Environmental or Animal Exposure:o Legionellosis.o Tularemia. o Plague. o Q fever. o Anthrax.

Streptococcus pneumoniae : Reservoir: nasopharynx of children and adults.

(patients or asymptomatic carriers). Transmission: droplets inhalation.Pathogenesis and microbial virulence:o Colonization of the nasopharynx then spread to the

bronchi and alveoli.o Polysaccharide capsule resist phagocytosis.o Production of pneumolysin: cholesterol-binding

toxin; epithelial cell-damage.o Production of hydrogen peroxide; cell damage, and

inhibition of other bacteria.o Inflammation: production of cytokines; TNFα,IL-1,

IL-8 by alveolar macrophage

(stages of pneumonia): Filling of alveoli by fluids*: many bacteria, and

few inflammatory cells. Early consolidation* stage; infiltration of alveoli

by neutrophils, activation of complement and CRP which interact with bacterial teichoic acid. (battle b/w the bacteria and the immune system).

Late Consolidation stage: heavy infiltration by neutrophils which kill the microbe helped by the specific Ab and complement, (Hepatization).

Infection eradication (resolution): Replacement of neutrophils by alveolar macrophages.

Clinical presentation: Acute lobar pneumonia.

Classic bacterial pathogenesis: R

Lobar Pneumonia

N

Complications of Streptococcus pneumonia: Local complications: Pleural effusion; Outpouring of fluid into pleural

space in 25% of cases. Empyema (pus in the pleura): in 1% of cases,

require drainage of fluid. Systemic complications: • Bacteremia (pneumococcemia): through

lymphatic vessels of the lung to thoracic duct.• Positive blood culture in only 25% of cases

(transient bacteremia).

• Defense: humoral factors and lymphatic system to remove the bacteria from the blood.

• Meningitis esp. in splenectomy, sickle cell anaemia

Diagnosis of S. pneumoniae:

• Clinical specimens: Sputum, transtracheal aspirate, broncheoalveolar lavage or lung biopsy.• Direct Microscopy:Streptococcus pneumoniae are Gram positive lanceolate (lancet shaped) diplococci arranged in pairs or chains, and capsulated.• Cultural characteristics:Facultative anaerobic bacteria, alpha hemolytic on blood agar, optochin sensitive.

Direct Microscopy: Gram positive capsulated cocci

N

Blood agar: α hemolysis & optochin sensitive

Streptococcus pneumoniaeStreptococcus mitis

N

Haemophilus influenzae-Gram negative coccobacilli, rod-shaped to pleomorphic.- Epiglottitis, tracheobronchitis and pneumonia.

N

Isolation of Haemophilus influenzae :-Aerobic or facultative anaerobic bacteria .

-Isolated on chocolate agar or factor X (hemin) and factor V (NAD).

-Satellitism phenomenon.

Satellitism around S.aureus.

N

Treatment of S. pneumoniae and H. influenzae:• Beta-lactam antibiotic.• If the patient is allergic to penicillin or the

bacteria is not sensitive: macrolide or fluoroquinolones.

• Penicillin-resistant streptococcus due to mutation in penicillin-binding protein by transformation.

Vaccine: -Conjugated capsular antigen vaccines for S. pneumoniae and H. influenzae type b.

Atypical bacterial pneumonia:

Chlamydophila pneumoniae: • Infective stage: Elementary bodies.-Target cells: columnar epithelial cells, endothelial cells of the vessels and macrophages.- Receptor-mediated endocytosis (intracellular infection).- Lymphocytic infiltration; IF-γ creates persistence infection by slowing the growth of the RB. • Diagnostic stage: Reticulate bodies.

Life cycle of C. pneumoniae

Clinical presentation: Acute tracheobronchitis. Bronchopneumonia (patchy infiltrates on

radiography). C. pneumoniae is associated with Coronary

artery disease (CAD):o Adults with CAD have a high antibodies titer

against this bacterium.o The microbe can be isolated from

atherosclerotic lesions.o The microbe established CAD in animal

model studies.

bronchopneumonia

N

Diagnosis: • Immunofluorescent microscopy for antigen and

antibodies detection.• PCR. Treatment:- Macrolide: Long-term Cmax (maximum serum concentration) of azithromycin. - Or doxycycline for 7 days.- Pregnant women: erythromycin or azithromycin.

N

Mycoplasma pneumoniae:• Smallest prokaryotes that lack cell-wall.• Infect mainly individuals aged 5-20 years old.• Pathogenesis:

Tip structure mediated attachment to carbohydrate containing receptor on columnar epithelial cells.

The infection is not highly destructive but the ciliary function is impaired. Exotoxins:• ADP-ribosyltransferase: inhibition of neutrophils

chemotaxis and phagocytosis.• Vacuolating toxin: apoptosis of ciliated cells. • Monocytic infiltration. (few neutrophils)

N

Clinical presentation: • Tracheobronchitis (persistent dry cough). • Bronchopneumonia; (infiltration of

monocytes with few neutrophils); patchy infiltrate on radiography.

• In 50% of severe mycoplasma infections; mild-autoimmune hemolytic anemia* due to cold hemagglutinin formation.

Complications:• Encephalitis, renal disease and arthritis

(antibody complex), autoimmune thrombocytopenic purpura** (erythema multiforme).

N

Diagnosis:-Direct: PCR or Immunofluorescent microscopy.-Indirect: serology: Complement fixation or cold agglutinin test. Treatment:-Macrolide.-Resistance strains; Tetracycline or Fluoroquinolones.